Overview
Prepare to gamble with your very genetic code in Gene Jackpot, a unique roguelike deckbuilder developed and published by Yes Games. As G-00, a gene experiment, your mission is to escape a clandestine biotech corporation's underground facility. The core mechanic revolves around weaponizing your own DNA, where playing specific gene cards directly impacts your character's physical form and abilities. Imagine playing a 'Strength' gene to develop massive arms or a 'Toxin' gene to alter your skin's appearance. The strategic depth comes from how these genetic modifications interact and evolve throughout your runs.
Highlights
- Unique DNA-Based Deckbuilding: Utilize your own genetic code as your deck, with cards like 'Strength,' 'Toxin,' and 'Electric' genes directly altering your character's body and abilities.
- Roguelike with a Twist: Defeat isn't the end. Unpredictable 'contamination mutations' reshape your character with each failure, potentially creating powerful, bizarre synergies or new challenges. Losing can be a strategic advantage, but three knockouts mean the end of your run.
- Strategic PvE Gameplay: Engage in turn-based tactical combat where your evolving genetic makeup is key to overcoming the obstacles within the underground lab.
Who It's For
Gene Jackpot is designed for players who enjoy strategic card battlers and deckbuilding roguelites with a strong emphasis on emergent gameplay. If you appreciate mechanics that allow for creative problem-solving and don't mind a bit of risk-taking where failure can lead to unexpected advantages, this game should pique your interest. The concept of weaponizing one's own DNA offers a fresh take on the genre.
Game Info
Developed and published by Yes Games, Gene Jackpot offers a compelling PvE experience. It features turn-based tactics and roguelite elements, all centered around a card battler system where your genes are your cards. The game supports a wide array of languages, ensuring accessibility for a global audience. It was released on April 28, 2026, and is available as a paid title.





